File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Safety and Antitumor Activity of Nivolumab (Nivo) in Patients (pts) with Advanced Hepatocellular Carcinoma (HCC): Interim Analysis of Dose-Expansion Cohorts from the Phase 1/2 CheckMate-040 Study

TitleSafety and Antitumor Activity of Nivolumab (Nivo) in Patients (pts) with Advanced Hepatocellular Carcinoma (HCC): Interim Analysis of Dose-Expansion Cohorts from the Phase 1/2 CheckMate-040 Study
Authors
Sangro, BMelero, IYau, TCCHsu, CKudo, MCrocenzi, TSKim, TYChoo, SPTrojan, JMeyer, TKang, YKAnderson, Jdela Cruz, CLang, LNeely, JEl-Khoueiry, AB
Issue Date2016
PublisherS. Karger AG. The Journal's web site is located at http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=255487
Citation
The 7th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2016): Advancing HCC Management through Multi-Disciplinary Approach, Hong Kong SAR, China, 8-10 July 2016: Abstracts. In Liver Cancer, 2016, v. 5 n. Suppl. 1, p. 47-48 How to Cite?
DOI: http://dx.doi.org/10.1159/000443566
DescriptionSession 9: Best Oral Presentation: no. 0110
Persistent Identifierhttp://hdl.handle.net/10722/236874
ISSN
2235-1795
2023 Impact Factor: 11.6
2023 SCImago Journal Rankings: 3.599

 

DC FieldValueLanguage
dc.contributor.authorSangro, B-
dc.contributor.authorMelero, I-
dc.contributor.authorYau, TCC-
dc.contributor.authorHsu, C-
dc.contributor.authorKudo, M-
dc.contributor.authorCrocenzi, TS-
dc.contributor.authorKim, TY-
dc.contributor.authorChoo, SP-
dc.contributor.authorTrojan, J-
dc.contributor.authorMeyer, T-
dc.contributor.authorKang, YK-
dc.contributor.authorAnderson, J-
dc.contributor.authordela Cruz, C-
dc.contributor.authorLang, L-
dc.contributor.authorNeely, J-
dc.contributor.authorEl-Khoueiry, AB-
dc.date.accessioned2016-12-13T06:20:20Z-
dc.date.available2016-12-13T06:20:20Z-
dc.date.issued2016-
dc.identifier.citationThe 7th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2016): Advancing HCC Management through Multi-Disciplinary Approach, Hong Kong SAR, China, 8-10 July 2016: Abstracts. In Liver Cancer, 2016, v. 5 n. Suppl. 1, p. 47-48-
dc.identifier.issn2235-1795-
dc.identifier.urihttp://hdl.handle.net/10722/236874-
dc.descriptionSession 9: Best Oral Presentation: no. 0110-
dc.languageeng-
dc.publisherS. Karger AG. The Journal's web site is located at http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=255487-
dc.relation.ispartofLiver Cancer-
dc.rightsLiver Cancer. Copyright © S. Karger AG.-
dc.titleSafety and Antitumor Activity of Nivolumab (Nivo) in Patients (pts) with Advanced Hepatocellular Carcinoma (HCC): Interim Analysis of Dose-Expansion Cohorts from the Phase 1/2 CheckMate-040 Study-
dc.typeConference_Paper-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.identifier.doi10.1159/000443566-
dc.identifier.volume5-
dc.identifier.issueSuppl. 1-
dc.identifier.spage47-
dc.identifier.epage48-
dc.publisher.placeSwitzerland-
dc.identifier.issnl1664-5553-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats